BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33118504)

  • 21. Convenient Method of Measuring Baseline Impedance for Distinguishing Patients with Functional Heartburn from those with Proton Pump Inhibitor-Resistant Endoscopic Negative Reflux Disease.
    Yoshimine T; Funaki Y; Kawamura Y; Tamura Y; Izawa S; Ebi M; Ogasawara N; Murotani K; Sasaki M; Kasugai K
    Digestion; 2019; 99(2):157-165. PubMed ID: 30179879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn.
    Savarino E; Zentilin P; Mastracci L; Dulbecco P; Marabotto E; Gemignani L; Bruzzone L; de Bortoli N; Frigo AC; Fiocca R; Savarino V
    J Gastroenterol; 2013 Apr; 48(4):473-82. PubMed ID: 23001252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Esophageal chemical clearance and baseline impedance values in patients with chronic autoimmune atrophic gastritis and gastro-esophageal reflux disease.
    Tenca A; de Bortoli N; Mauro A; Frazzoni M; Savarino E; Massironi S; Russo S; Bertani L; Marchi S; Penagini R
    Dig Liver Dis; 2017 Sep; 49(9):978-983. PubMed ID: 28487082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-erosive reflux disease (NERD)--acid reflux and symptom patterns.
    Martinez SD; Malagon IB; Garewal HS; Cui H; Fass R
    Aliment Pharmacol Ther; 2003 Feb; 17(4):537-45. PubMed ID: 12622762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid.
    Shapiro M; Green C; Bautista JM; Peru RL; Malagon IB; Corvo M; Risner-Adler S; Beeler JN; Tuchinsky I; Fass R
    Am J Gastroenterol; 2006 May; 101(5):1084-91. PubMed ID: 16573776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Esophageal acid sensitivity and mucosal integrity in patients with functional heartburn.
    Weijenborg PW; Smout AJ; Bredenoord AJ
    Neurogastroenterol Motil; 2016 Nov; 28(11):1649-1654. PubMed ID: 27194216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn.
    Kandulski A; Jechorek D; Caro C; Weigt J; Wex T; Mönkemüller K; Malfertheiner P
    Aliment Pharmacol Ther; 2013 Sep; 38(6):643-51. PubMed ID: 23895770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acid reflux episodes sensitize the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease patients.
    Emerenziani S; Ribolsi M; Guarino MP; Balestrieri P; Altomare A; Rescio MP; Cicala M
    Neurogastroenterol Motil; 2014 Jan; 26(1):108-14. PubMed ID: 24118616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of baseline impedance in patients with proton pump inhibitor-refractory nonerosive reflux disease.
    Kohata Y; Fujiwara Y; Yamagami H; Tanigawa T; Shiba M; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():36-40. PubMed ID: 25827802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Esophageal Mean Nocturnal Baseline Impedance and Post-reflux Swallow-induced Peristaltic Wave Index in Discriminating Chinese Patients With Heartburn.
    Sun YM; Gao Y; Gao F
    J Neurogastroenterol Motil; 2019 Oct; 25(4):515-520. PubMed ID: 31587542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy.
    Savarino E; Tutuian R; Zentilin P; Dulbecco P; Pohl D; Marabotto E; Parodi A; Sammito G; Gemignani L; Bodini G; Savarino V
    Am J Gastroenterol; 2010 May; 105(5):1053-61. PubMed ID: 19997095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Impedance-pH Monitoring of Patients With Reflux Disease.
    Frazzoni M; Savarino E; de Bortoli N; Martinucci I; Furnari M; Frazzoni L; Mirante VG; Bertani H; Marchi S; Conigliaro R; Savarino V
    Clin Gastroenterol Hepatol; 2016 Jan; 14(1):40-6. PubMed ID: 26122764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.
    Kawamura O; Hosaka H; Shimoyama Y; Kawada A; Kuribayashi S; Kusano M; Yamada M
    Digestion; 2015; 91(1):19-25. PubMed ID: 25632912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the different characteristics of sensed reflux events among different heartburn groups.
    Schey R; Shapiro M; Navarro-Rodriguez T; Fass SS; Han B; Wendel C; Fass R
    J Clin Gastroenterol; 2009 Sep; 43(8):699-704. PubMed ID: 18797407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precise role of acid in non-erosive reflux disease.
    Wang C; Hunt RH
    Digestion; 2008; 78 Suppl 1():31-41. PubMed ID: 18832838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives.
    Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Savarino V; Savarino E
    Dig Dis Sci; 2017 Aug; 62(8):1881-1889. PubMed ID: 28550489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of the pH Value of Refluxate and Proximal Extent on Heartburn Perception in Patients with Proton Pump Inhibitor-Refractory Non-Erosive Reflux Disease.
    Abe Y; Koike T; Saito M; Okata T; Norita K; Kikuchi H; Nakagawa K; Hatta W; Asanuma K; Uno K; Asano N; Imatani A; Shimosegawa T; Masamune A
    Digestion; 2020; 101(4):375-381. PubMed ID: 31357199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative assessment and characterization of visceral hyperalgesia evoked by esophageal balloon distention and acid perfusion in patients with functional heartburn, nonerosive reflux disease, and erosive esophagitis.
    Yang M; Li ZS; Chen DF; Zou DW; Xu XR; Fang DC; Xu GM; Stephens RL; Wang ZG
    Clin J Pain; 2010 May; 26(4):326-31. PubMed ID: 20393268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group.
    Lee KJ; Kwon HC; Cheong JY; Cho SW
    Digestion; 2009; 79(3):131-6. PubMed ID: 19307735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Distal Mean Nocturnal Baseline Impedance in Differentiating GERD Phenotypes.
    Sararu R; Peagu R; Fierbinteanu-Braticevici C
    J Gastrointestin Liver Dis; 2023 Sep; 32(3):291-297. PubMed ID: 37774210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.